This industry profile provides a five-year forecast for Canada’s Pharmaceutical Products Industry.
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2015
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2015
Industry Economic Analysis
$635.00
- Research and Development—R&D spending as a share of total sales has declined for five consecutive years and is at its lowest point in more than two decades.
- Prices—With generics’ share of the market growing and provincial governments seeking to limit costs, the medium-term outlook for prices is weak.
- Demand—The aging of the population in Canada and a shift toward chronic and long-term care will provide stronger demand for the industry’s products in the years ahead.
Customers Who Downloaded This Also Liked
10 min read
10 min read
10 min read
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
